Explore E-Briefings
E-briefings are published weekly and are listed below, with the most recent at the top. You may filter by topic and access dozens of additional articles using the page navigation below. Check back often to access new articles online or subscribe to have each new article delivered straight to your inbox weekly!
Blue Care Network of Michigan to Launch Pharmacogenomic Personalized Medicine Program
The adoption of a precision medicine program by such a large insurer is expected to significantly expand the availability of precision medicine options within the state.
University of California Irvine Launches Institute for Precision Health, Signaling Increased Academic Emphasis on Precision Medicine
University of California, Irvine launches Institute for Precision Health, signaling increased academic emphasis on precision medicine.
MIT and Massachusetts General Hospital Researchers Are Developing Machine Learning Algorithms to Provide Physicians and Patients with Early Recognition of Mental Health Changes
Person-generated wearable device data may be usefu in precision medicine for the purpose of early intervention and personalized treatment of major depression.
Weill Cornell Medicine Develops Precision Medicine Technology Specifically Designed for Screening Citizens of Qatar
This precision medicine development involves use of a specialized chip which provides genetic screening for heritable diseases in an area with unique population traits.
Precision Medicine May Help 50-Year-Old Cancer Drug Bring More Accurate Treatment, New Research Shows
Hospitals and oncology groups may be able to apply modern precision medicine principles to a 50-year-old cancer drug, increasing the drug’s effectiveness for breast cancer patients.
University of Florida Scientists Use Genetics to Develop Precision Medicine Score for Children’s Leukemia Treatments
Method genetically defines patients who would benefit from intensifying the chemotherapy, adding a new drug, or having chemotherapy reduced to avoid toxicity.
UMass Medical School Pilot Study Shows Modified Nucleotide Therapy Can Suppress Gene That Causes Lou Gehrig’s Disease
“While other teams have documented that this gene can be suppressed in cells in culture, this is the first time this type of antisense oligonucleotide treatment for C9ORF72 ALS has been demonstrated in a person with ALS.”
Advances in Understanding the Genetic Basis of Schizophrenia May Lead to Personalized Psychiatric Diagnostics and Therapeutics
Emerging research that explores “intolerant” genes, the “dark genome,” and the value of doctors’ notes compared to genetic testing in diagnosing schizophrenia.
Precision Medicine Testing Executives Face Federal Jail Time After Violating Anti-Kickback Laws for Pharmacogenetic Testing
Illegal financial underpinnings brought charges in a large conspiracy involving iIllicit payment schemes for certain kinds of precision medicine testing.
Stanford Researchers Develop Precision Medicine Method for Guiding Tuberculosis Drug Dosages
Stanford Medicine researchers have developed a precision medicine method for determining personalized doses of a drug used to treat tuberculosis.